| Filed 2021-11-07 18:59 Tx date 2021-11-03 | $ATE
Antibe Therapeutics Inc. | Macnee, Walter Minnes 4 - Director of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $24,385
+25,000 vol
$0.98 each | 447,027 | |
| Older filings |
| Filed 2021-11-03 16:59 Tx date 2021-11-01 | $ATE
Antibe Therapeutics Inc. | Wu, Yung Cheng 4 - Director of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $23,265
+23,500 vol
$0.99 each | 279,333 | |
| Filed 2021-11-03 16:58 Tx date 2021-11-01 | $ATE
Antibe Therapeutics Inc. | Wu, Yung Cheng 4 - Director of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $3,430
+3,500 vol
$0.98 each | 255,833 | |
| Filed 2021-11-03 16:58 Tx date 2021-11-01 | $ATE
Antibe Therapeutics Inc. | Wu, Yung Cheng 4 - Director of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $960.00
+1,000 vol
$0.96 each | 252,333 | |
| Filed 2021-11-03 16:57 Tx date 2021-11-01 | $ATE
Antibe Therapeutics Inc. | Wu, Yung Cheng 4 - Director of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $6,175
+6,500 vol
$0.95 each | 251,333 | |
| Filed 2021-11-03 16:56 Tx date 2021-11-01 | $ATE
Antibe Therapeutics Inc. | Wu, Yung Cheng 4 - Director of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $19,740
+21,000 vol
$0.94 each | 244,833 | |
| Filed 2021-11-03 16:55 Tx date 2021-11-01 | $ATE
Antibe Therapeutics Inc. | Wu, Yung Cheng 4 - Director of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $4,650
+5,000 vol
$0.93 each | 223,833 | |
| Filed 2021-11-03 16:55 Tx date 2021-11-01 | $ATE
Antibe Therapeutics Inc. | Wu, Yung Cheng 4 - Director of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $2,275
+2,500 vol
$0.91 each | 218,833 | |
| Filed 2021-11-03 16:54 Tx date 2021-11-01 | $ATE
Antibe Therapeutics Inc. | Wu, Yung Cheng 4 - Director of Issuer Direct Ownership | Common Shares 10 - Acquisition or disposition in the public market | $22,250
+25,000 vol
$0.89 each | 216,333 |